Intellectual Property India Publishes Patent Application for 'Low Dose Il-6 Formulations And Methods Of Use Thereof' Filed by Sonnet Biotherapeutics, Inc.

MUMBAI, India, May 9 -- Intellectual Property India has published a patent application (202517036816 A) filed by Sonnet Biotherapeutics, Inc., Princeton, U.S.A., on April 16, for 'low dose il-6 formulations and methods of use thereof.'

Inventor(s) include Cini, John, K.; Gadgil, Himanshu; Gadgil, Shilpa; Chauhan, Nildip; and Kolapkar, Varda.

The application for the patent was published on May 9, under issue no. 19/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides an IL-6 formulation, comprising about 40 g/mL to about 2 mg/ml IL-6, about 5 to about 15 mM histidine, about 5 to about 15 mg/mL glycine, about 40 to about 60 mg/mL trehalose, about 0.1 to about 0.3 mg/mL polysorbate 20...